COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 966: Articles 9651-9660  | Next

COVID-19 vaccination breakthrough infections in a real-world setting: Using community reporters to evaluate vaccine effectiveness
Reynolds, M. W., Xie, Y., Knuth, K. B., Mack, C. D., Brinkley, E., Toovey, S., Dreyer, N. A.
10.1101/2022.01.11.22268736 — Posted: 2022-01-11
Systematic review and meta-analysis of COVID-19 vaccines safety, tolerability, and efficacy among HIV-infected patients
Tamuzi, J. J., Muyaya, L. M., Mitra, A., Nyasulu, P.
10.1101/2022.01.11.22269049 — Posted: 2022-01-11
Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19.
Jacobs, J., Naqvi, A., Shah, F., Boltz, V., Kearney, M., McVerry, B., Ray, P., Schaefer, C., Fitzpatrick, M., Methe, B., Lee, J., Morris, A., Mellors, J., Kitsios, G., Bain, W.
10.1101/2022.01.10.22269018 — Posted: 2022-01-11
Impact of COVID-19 Pandemic on Utilization of Facility-Based Essential Maternal and Child Health Services in North Shewa Zone, Ethiopia
Bekele, C., Bekele, D., Hunegnaw, B., Van Wickle, K., Ashenafi, F., Korte, M., Tedijanto, C., Tadesse, L., Chan, G.
10.1101/2022.01.10.22268794 — Posted: 2022-01-11
Covid-19 disease dynamics with vaccination: The effect of uncertainty
Bairagi, N., Majumder, A.
10.1101/2022.01.10.22269006 — Posted: 2022-01-11
Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens
Fraser, D. D., Miller, M. R., Martin, C. M., Slessarev, M., Hahn, P., Higgins, I., Melo, C., Pest, M. A., Rothery, N., Wang, X., Zeidler, J., Cruz-Aguado, J. A.
10.1101/2022.01.10.21268250 — Posted: 2022-01-11
EFFECT OF FULL VACCINATION AND POST-COVID OLFACTORY DYSFUNCTION IN RECOVERED COVID-19 PATIENT. A RETROSPECTIVE LONGITUDINAL STUDY WITH PROPENSITY MATCHING.
Herman, B., Viwattanakulvanid, P., Dzulhadj, A., Oo, A. C., Patricia, K., Pongpanich, S.
10.1101/2022.01.10.22269007 — Posted: 2022-01-11
Healthcare workers' views on mandatory SARS-CoV-2 vaccination in the United Kingdom: findings from the UK-REACH prospective longitudinal cohort study
Woolf, K., Gogoi, M., Martin, C. A., Panineni, P., Lagrata, S., Nellums, L. B., McManus, C., Guyatt, A. L., Melbourne, C., Bryant, L., Gupta, A., John, C., Carr, S., Tobin, M. D., Simpson, S., Gregary, B., Aujayeb, A., Zingwe, S., Reza, R., Gray, L. J., Khunti, K., Pareek, M.
10.1101/2022.01.11.22269017 — Posted: 2022-01-11
Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: Protocol for an observational cohort study (LongCOVID-study)
Mutubuki, E. N., van der Maaden, T., Leung, K. Y., Wong, A., Tulen, A. D., de Bruijn, S., Haverman, L., Knoop, H., Eelco, E., van Hoek, A. J., van den Wijngaard, C. C.
10.1101/2022.01.10.22269009 — Posted: 2022-01-11
The Psychosocial Benefits of Sport Participation During COVID-19 Are Only Partially Explained by Increased Physical Activity
Watson, A. M., Biese, K., Reardon, C., Schwarz, A., Haraldsdottir, K., Brooks, M. A., Bell, D. R., McGuine, T.
10.1101/2022.01.11.22269077 — Posted: 2022-01-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).